Interim Effectiveness and Safety of Prolonged Bedaquiline Use in Comparison to Standard 24-Week Treatment for MDR-TB: A Multicenter Cohort Study in China

Hu X, Gao M, Liu Y, Pei Y, Du J, Wu G, Wang A, Li L, Gao J

Infection and Drug Resistance 2026, 19:572423

Published Date: 10 March 2026

Treatment Outcomes and Associated Influencing Factors Among Patients with Rifampicin-Resistant Tuberculosis: A Multicenter, Retrospective, Cohort Study in China

Zou L, Kang W, Guo C, Du J, Chen Q, Shi Z, Tang X, Liang L, Tang P, Pan Q, Zhu Q, Yang S, Chang Z, Guo Z, Wu G, Tang S

Infection and Drug Resistance 2024, 17:3737-3749

Published Date: 28 August 2024